Heparin Sodium Injection, Solution
Product Images NDC 63323-522

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 63323-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fre0i 0000 01)

Chemical Structure (Fre0i 0000 01)
Chemical structure of Heparin Sodium, showing its complex polysaccharide chain with multiple sulfate and hydroxyl groups. The schematic depicts five sugar ring components labeled (1) through (5), illustrating the molecular composition of this anticoagulant compound.*
FDA Label Image

Fresenius Kabi Logo (Fre0i 0000 02)

FDA Label Image

Bag Label (Fre0i 0000 03)

Bag Label (Fre0i 0000 03)
Heparin Sodium 25,000 USP units per 500 mL injection solution label showing 0.45% Sodium Chloride. Single dose container for intravenous use by Fresenius Kabi USA, LLC. The label lists ingredients, electrolytes content, storage instructions, and manufacturer details including origin from Norway.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Heparin Sodium in 0.45% Sodium Chloride Injection label showing a 500 mL x 24 count package. The label includes storage instructions at 20° to 25°C (68° to 77°F), caution to avoid heat and freezing, and manufacturing details by Fresenius Kabi USA, LLC in Lake Zurich, IL, made in Norway. It includes barcodes, expiration, lot number placeholders, and NDC 63323-518-77.*
FDA Label Image

Bag Label (Fre0i 0000 05)

Bag Label (Fre0i 0000 05)
Heparin Sodium Injection, 25,000 USP units per 250 mL (100 USP units per mL) in 0.45% Sodium Chloride solution. This label shows a single-dose container for intravenous use only, manufactured by Fresenius Kabi USA, LLC. It includes active ingredient and electrolyte details, storage instructions, and cautions against admixing with other drugs.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Packaging label for Heparin Injection, labeled as Heparin Sodium in 0.45% Sodium Chloride Injection. The label shows a volume of 250 mL with a quantity of 24, for intravenous use. Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, and made in Norway. Storage instructions indicate temperature between 20° to 25°C (68° to 77°F). The label includes expiration and lot number placeholders as well as barcodes.*
FDA Label Image

Bag Label (Fre0i 0000 07)

Bag Label (Fre0i 0000 07)
Heparin Sodium 25,000 USP units per 500 mL injection in 5% Dextrose solution. This single-dose, intravenous injection contains heparin sodium 5,000 USP units per 100 mL and other ingredients including dextrose, sodium citrate, citric acid, and sodium metabisulfite. Labeler is Fresenius Kabi USA, LLC, with storage instructions at 20° to 25°C and a note that the container closure is not made with natural rubber latex.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Heparin Sodium in 5% Dextrose Injection, intravenous solution. The product is packaged as 500 mL bottles with a quantity of 24 per package. It is manufactured for Fresenius Kabi USA, LLC, made in Norway. Storage instructions specify 20° to 25°C (68° to 77°F). The label includes an NDC number 63323-522-77 and barcodes.*
FDA Label Image

Bag Label (Fre0i 0000 09)

Bag Label (Fre0i 0000 09)
Label for Heparin Sodium injection in 5% Dextrose solution, providing 25,000 USP units per 250 mL (100 USP units per mL). The label includes dosage form (injection), route (intravenous), and formulation details. It indicates a single-dose container, usage instructions, and storage conditions. The label also lists ingredients and electrolytes per 100 mL and identifies Fresenius Kabi USA, LLC as the labeler, with manufacturing in Norway.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Heparin Sodium in 5% Dextrose Injection, 250 mL bags, with a total quantity of 24. The label includes storage instructions to keep between 20° to 25°C (68° to 77°F), with warnings to avoid excessive heat and freezing. Manufactured for Fresenius Kabi USA, LLC in Lake Zurich, Illinois, made in Norway. The label displays the product number 507374 and NDC 63323-523-74.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.